XBIT Long Call Strategy
XBIT (XBiotech Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
XBiotech Inc. is a biopharmaceutical firm specializing in the discovery, development, and commercialization of True Human monoclonal antibodies. Their primary focus involves building a robust pipeline of product candidates aimed at combating both inflammatory and infectious diseases. Furthermore, the company is advancing interleukin-1 alpha-based therapies, which are designed to address a broad spectrum of medical conditions such as cancer, stroke, heart attack, and arthritis. Interleukin-1 alpha itself plays a crucial role in biological processes like tissue breakdown, angiogenesis, blood clot formation, malaise, muscle wasting, and inflammation. Additionally, XBiotech is developing a True Human COVID-19 therapy specifically targeting mutant strains of the virus. Established in 2005, XBiotech Inc. maintains its headquarters in Austin, Texas.
XBIT (XBiotech Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $75.0M, a beta of 0.85 versus the broader market, a 52-week range of 2.09-3.61, average daily share volume of 31K, a public-listing history dating back to 2015, approximately 87 full-time employees. These structural characteristics shape how XBIT stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.85 places XBIT roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. XBIT pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a long call on XBIT?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
XBIT snapshot
As of August 14, 2026, spot at $2.34, ATM IV 62.40%, IV rank 10.05%, expected move 15.74%. The long call on XBIT below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this long call structure on XBIT specifically: XBIT IV at 62.40% is on the cheap side of its 1-year range, which favors premium-buying structures like a XBIT long call, with a market-implied 1-standard-deviation move of approximately 15.74% (roughly $0.37 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated XBIT expiries trade a higher absolute premium for lower per-day decay. Position sizing on XBIT should anchor to the underlying notional of $2.34 per share and to the trader's directional view on XBIT stock.
XBIT long call setup
The XBIT long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With XBIT at $2.34 on that close, the first option leg uses a $2.34 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed XBIT chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 XBIT shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $2.34 | N/A |
XBIT long call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
XBIT long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on XBIT. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long call on XBIT
Long calls on XBIT express a bullish thesis with defined risk; traders use them ahead of XBIT catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
XBIT thesis for this long call
The market-implied 1-standard-deviation range for XBIT extends from approximately $1.97 on the downside to $2.71 on the upside. A XBIT long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current XBIT IV rank near 10.05% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on XBIT at 62.40%. As a Healthcare name, XBIT options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to XBIT-specific events.
XBIT long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. XBIT positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move XBIT alongside the broader basket even when XBIT-specific fundamentals are unchanged. Long-premium structures like a long call on XBIT are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current XBIT chain quotes before placing a trade.
Frequently asked questions
- What is a long call on XBIT?
- A long call on XBIT is the long call strategy applied to XBIT (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With XBIT stock at $2.34 on the most recent close, the strikes shown on this page are snapped to the nearest listed XBIT chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are XBIT long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the XBIT long call priced from the end-of-day chain at a 30-day expiry (ATM IV 62.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a XBIT long call?
- The breakeven for the XBIT long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The XBIT market-implied 1-standard-deviation expected move in the same options snapshot is approximately 15.74%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on XBIT?
- Long calls on XBIT express a bullish thesis with defined risk; traders use them ahead of XBIT catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current XBIT implied volatility affect this long call?
- XBIT ATM IV is at 62.40% with IV rank near 10.05%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.